Medical Care

Global Stem Cell Biomanufacturing Market Research Report 2026

This report delivers a comprehensive overview of the global Stem Cell Biomanufacturing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Stem Cell Biomanufacturing. The Stem Cell Biomanufacturing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Stem Cell Biomanufacturing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Stem Cell Biomanufacturing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Biosenic
Bristol-Myers Squibb
Danaher Life Sciences
Iovance Biotherapeutics
Lisata Therapeutics
Lonza
Merck KGaA
Thermo Fisher Scientific
Segment by Type
Equipment
Software
Consumables
Segment by Application
Skeletal Muscle Repair
Bone Repair
Cancer
Cardiovascular Diseases
Neurological Disorders
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Stem Cell Biomanufacturing companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stem Cell Biomanufacturing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Equipment
1.2.3 Software
1.2.4 Consumables
1.3 Market by Application
1.3.1 Global Stem Cell Biomanufacturing Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Skeletal Muscle Repair
1.3.3 Bone Repair
1.3.4 Cancer
1.3.5 Cardiovascular Diseases
1.3.6 Neurological Disorders
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stem Cell Biomanufacturing Market Perspective (2021–2032)
2.2 Global Stem Cell Biomanufacturing Growth Trends by Region
2.2.1 Global Stem Cell Biomanufacturing Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Stem Cell Biomanufacturing Historic Market Size by Region (2021–2026)
2.2.3 Stem Cell Biomanufacturing Forecasted Market Size by Region (2027–2032)
2.3 Stem Cell Biomanufacturing Market Dynamics
2.3.1 Stem Cell Biomanufacturing Industry Trends
2.3.2 Stem Cell Biomanufacturing Market Drivers
2.3.3 Stem Cell Biomanufacturing Market Challenges
2.3.4 Stem Cell Biomanufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stem Cell Biomanufacturing Players by Revenue
3.1.1 Global Top Stem Cell Biomanufacturing Players by Revenue (2021–2026)
3.1.2 Global Stem Cell Biomanufacturing Revenue Market Share by Players (2021–2026)
3.2 Global Top Stem Cell Biomanufacturing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Stem Cell Biomanufacturing Revenue
3.4 Global Stem Cell Biomanufacturing Market Concentration Ratio
3.4.1 Global Stem Cell Biomanufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Biomanufacturing Revenue in 2025
3.5 Global Key Players of Stem Cell Biomanufacturing Head Offices and Areas Served
3.6 Global Key Players of Stem Cell Biomanufacturing, Products and Applications
3.7 Global Key Players of Stem Cell Biomanufacturing, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Stem Cell Biomanufacturing Breakdown Data by Type
4.1 Global Stem Cell Biomanufacturing Historic Market Size by Type (2021–2026)
4.2 Global Stem Cell Biomanufacturing Forecasted Market Size by Type (2027–2032)
5 Stem Cell Biomanufacturing Breakdown Data by Application
5.1 Global Stem Cell Biomanufacturing Historic Market Size by Application (2021–2026)
5.2 Global Stem Cell Biomanufacturing Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Stem Cell Biomanufacturing Market Size (2021–2032)
6.2 North America Stem Cell Biomanufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Stem Cell Biomanufacturing Market Size by Country (2021–2026)
6.4 North America Stem Cell Biomanufacturing Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Stem Cell Biomanufacturing Market Size (2021–2032)
7.2 Europe Stem Cell Biomanufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Stem Cell Biomanufacturing Market Size by Country (2021–2026)
7.4 Europe Stem Cell Biomanufacturing Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Stem Cell Biomanufacturing Market Size (2021–2032)
8.2 Asia-Pacific Stem Cell Biomanufacturing Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Stem Cell Biomanufacturing Market Size by Region (2021–2026)
8.4 Asia-Pacific Stem Cell Biomanufacturing Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Stem Cell Biomanufacturing Market Size (2021–2032)
9.2 Latin America Stem Cell Biomanufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Stem Cell Biomanufacturing Market Size by Country (2021–2026)
9.4 Latin America Stem Cell Biomanufacturing Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stem Cell Biomanufacturing Market Size (2021–2032)
10.2 Middle East & Africa Stem Cell Biomanufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Stem Cell Biomanufacturing Market Size by Country (2021–2026)
10.4 Middle East & Africa Stem Cell Biomanufacturing Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biosenic
11.1.1 Biosenic Company Details
11.1.2 Biosenic Business Overview
11.1.3 Biosenic Stem Cell Biomanufacturing Introduction
11.1.4 Biosenic Revenue in Stem Cell Biomanufacturing Business (2021–2026)
11.1.5 Biosenic Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Stem Cell Biomanufacturing Introduction
11.2.4 Bristol-Myers Squibb Revenue in Stem Cell Biomanufacturing Business (2021–2026)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Danaher Life Sciences
11.3.1 Danaher Life Sciences Company Details
11.3.2 Danaher Life Sciences Business Overview
11.3.3 Danaher Life Sciences Stem Cell Biomanufacturing Introduction
11.3.4 Danaher Life Sciences Revenue in Stem Cell Biomanufacturing Business (2021–2026)
11.3.5 Danaher Life Sciences Recent Development
11.4 Iovance Biotherapeutics
11.4.1 Iovance Biotherapeutics Company Details
11.4.2 Iovance Biotherapeutics Business Overview
11.4.3 Iovance Biotherapeutics Stem Cell Biomanufacturing Introduction
11.4.4 Iovance Biotherapeutics Revenue in Stem Cell Biomanufacturing Business (2021–2026)
11.4.5 Iovance Biotherapeutics Recent Development
11.5 Lisata Therapeutics
11.5.1 Lisata Therapeutics Company Details
11.5.2 Lisata Therapeutics Business Overview
11.5.3 Lisata Therapeutics Stem Cell Biomanufacturing Introduction
11.5.4 Lisata Therapeutics Revenue in Stem Cell Biomanufacturing Business (2021–2026)
11.5.5 Lisata Therapeutics Recent Development
11.6 Lonza
11.6.1 Lonza Company Details
11.6.2 Lonza Business Overview
11.6.3 Lonza Stem Cell Biomanufacturing Introduction
11.6.4 Lonza Revenue in Stem Cell Biomanufacturing Business (2021–2026)
11.6.5 Lonza Recent Development
11.7 Merck KGaA
11.7.1 Merck KGaA Company Details
11.7.2 Merck KGaA Business Overview
11.7.3 Merck KGaA Stem Cell Biomanufacturing Introduction
11.7.4 Merck KGaA Revenue in Stem Cell Biomanufacturing Business (2021–2026)
11.7.5 Merck KGaA Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Stem Cell Biomanufacturing Introduction
11.8.4 Thermo Fisher Scientific Revenue in Stem Cell Biomanufacturing Business (2021–2026)
11.8.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Stem Cell Biomanufacturing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Equipment
Table 3. Key Players of Software
Table 4. Key Players of Consumables
Table 5. Global Stem Cell Biomanufacturing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Stem Cell Biomanufacturing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Stem Cell Biomanufacturing Market Size by Region (US$ Million), 2021–2026
Table 8. Global Stem Cell Biomanufacturing Market Share by Region (2021–2026)
Table 9. Global Stem Cell Biomanufacturing Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Stem Cell Biomanufacturing Market Share by Region (2027–2032)
Table 11. Stem Cell Biomanufacturing Market Trends
Table 12. Stem Cell Biomanufacturing Market Drivers
Table 13. Stem Cell Biomanufacturing Market Challenges
Table 14. Stem Cell Biomanufacturing Market Restraints
Table 15. Global Stem Cell Biomanufacturing Revenue by Players (US$ Million), 2021–2026
Table 16. Global Stem Cell Biomanufacturing Market Share by Players (2021–2026)
Table 17. Global Top Stem Cell Biomanufacturing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Stem Cell Biomanufacturing Revenue, 2025
Table 18. Ranking of Global Top Stem Cell Biomanufacturing Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Stem Cell Biomanufacturing Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Stem Cell Biomanufacturing, Headquarters and Area Served
Table 21. Global Key Players of Stem Cell Biomanufacturing, Products and Applications
Table 22. Global Key Players of Stem Cell Biomanufacturing, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Stem Cell Biomanufacturing Market Size by Type (US$ Million), 2021–2026
Table 25. Global Stem Cell Biomanufacturing Revenue Market Share by Type (2021–2026)
Table 26. Global Stem Cell Biomanufacturing Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Stem Cell Biomanufacturing Revenue Market Share by Type (2027–2032)
Table 28. Global Stem Cell Biomanufacturing Market Size by Application (US$ Million), 2021–2026
Table 29. Global Stem Cell Biomanufacturing Revenue Market Share by Application (2021–2026)
Table 30. Global Stem Cell Biomanufacturing Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Stem Cell Biomanufacturing Revenue Market Share by Application (2027–2032)
Table 32. North America Stem Cell Biomanufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Stem Cell Biomanufacturing Market Size by Country (US$ Million), 2021–2026
Table 34. North America Stem Cell Biomanufacturing Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Stem Cell Biomanufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Stem Cell Biomanufacturing Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Stem Cell Biomanufacturing Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Stem Cell Biomanufacturing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Stem Cell Biomanufacturing Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Stem Cell Biomanufacturing Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Stem Cell Biomanufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Stem Cell Biomanufacturing Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Stem Cell Biomanufacturing Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Stem Cell Biomanufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Stem Cell Biomanufacturing Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Stem Cell Biomanufacturing Market Size by Country (US$ Million), 2027–2032
Table 47. Biosenic Company Details
Table 48. Biosenic Business Overview
Table 49. Biosenic Stem Cell Biomanufacturing Product
Table 50. Biosenic Revenue in Stem Cell Biomanufacturing Business (US$ Million), 2021–2026
Table 51. Biosenic Recent Development
Table 52. Bristol-Myers Squibb Company Details
Table 53. Bristol-Myers Squibb Business Overview
Table 54. Bristol-Myers Squibb Stem Cell Biomanufacturing Product
Table 55. Bristol-Myers Squibb Revenue in Stem Cell Biomanufacturing Business (US$ Million), 2021–2026
Table 56. Bristol-Myers Squibb Recent Development
Table 57. Danaher Life Sciences Company Details
Table 58. Danaher Life Sciences Business Overview
Table 59. Danaher Life Sciences Stem Cell Biomanufacturing Product
Table 60. Danaher Life Sciences Revenue in Stem Cell Biomanufacturing Business (US$ Million), 2021–2026
Table 61. Danaher Life Sciences Recent Development
Table 62. Iovance Biotherapeutics Company Details
Table 63. Iovance Biotherapeutics Business Overview
Table 64. Iovance Biotherapeutics Stem Cell Biomanufacturing Product
Table 65. Iovance Biotherapeutics Revenue in Stem Cell Biomanufacturing Business (US$ Million), 2021–2026
Table 66. Iovance Biotherapeutics Recent Development
Table 67. Lisata Therapeutics Company Details
Table 68. Lisata Therapeutics Business Overview
Table 69. Lisata Therapeutics Stem Cell Biomanufacturing Product
Table 70. Lisata Therapeutics Revenue in Stem Cell Biomanufacturing Business (US$ Million), 2021–2026
Table 71. Lisata Therapeutics Recent Development
Table 72. Lonza Company Details
Table 73. Lonza Business Overview
Table 74. Lonza Stem Cell Biomanufacturing Product
Table 75. Lonza Revenue in Stem Cell Biomanufacturing Business (US$ Million), 2021–2026
Table 76. Lonza Recent Development
Table 77. Merck KGaA Company Details
Table 78. Merck KGaA Business Overview
Table 79. Merck KGaA Stem Cell Biomanufacturing Product
Table 80. Merck KGaA Revenue in Stem Cell Biomanufacturing Business (US$ Million), 2021–2026
Table 81. Merck KGaA Recent Development
Table 82. Thermo Fisher Scientific Company Details
Table 83. Thermo Fisher Scientific Business Overview
Table 84. Thermo Fisher Scientific Stem Cell Biomanufacturing Product
Table 85. Thermo Fisher Scientific Revenue in Stem Cell Biomanufacturing Business (US$ Million), 2021–2026
Table 86. Thermo Fisher Scientific Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
Table 90. Authors List of This Report


List of Figures
Figure 1. Stem Cell Biomanufacturing Picture
Figure 2. Global Stem Cell Biomanufacturing Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Stem Cell Biomanufacturing Market Share by Type: 2025 vs 2032
Figure 4. Equipment Features
Figure 5. Software Features
Figure 6. Consumables Features
Figure 7. Global Stem Cell Biomanufacturing Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Stem Cell Biomanufacturing Market Share by Application: 2025 vs 2032
Figure 9. Skeletal Muscle Repair Case Studies
Figure 10. Bone Repair Case Studies
Figure 11. Cancer Case Studies
Figure 12. Cardiovascular Diseases Case Studies
Figure 13. Neurological Disorders Case Studies
Figure 14. Others Case Studies
Figure 15. Stem Cell Biomanufacturing Report Years Considered
Figure 16. Global Stem Cell Biomanufacturing Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 17. Global Stem Cell Biomanufacturing Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global Stem Cell Biomanufacturing Market Share by Region: 2025 vs 2032
Figure 19. Global Stem Cell Biomanufacturing Market Share by Players in 2025
Figure 20. Global Stem Cell Biomanufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. The Top 10 and 5 Players Market Share by Stem Cell Biomanufacturing Revenue in 2025
Figure 22. North America Stem Cell Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. North America Stem Cell Biomanufacturing Market Share by Country (2021–2032)
Figure 24. United States Stem Cell Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Canada Stem Cell Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Stem Cell Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Europe Stem Cell Biomanufacturing Market Share by Country (2021–2032)
Figure 28. Germany Stem Cell Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. France Stem Cell Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. U.K. Stem Cell Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Italy Stem Cell Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Russia Stem Cell Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Ireland Stem Cell Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Stem Cell Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Asia-Pacific Stem Cell Biomanufacturing Market Share by Region (2021–2032)
Figure 36. China Stem Cell Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Japan Stem Cell Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. South Korea Stem Cell Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Southeast Asia Stem Cell Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. India Stem Cell Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Australia & New Zealand Stem Cell Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Stem Cell Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Latin America Stem Cell Biomanufacturing Market Share by Country (2021–2032)
Figure 44. Mexico Stem Cell Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Brazil Stem Cell Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Stem Cell Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Middle East & Africa Stem Cell Biomanufacturing Market Share by Country (2021–2032)
Figure 48. Israel Stem Cell Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Saudi Arabia Stem Cell Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. UAE Stem Cell Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Biosenic Revenue Growth Rate in Stem Cell Biomanufacturing Business (2021–2026)
Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Stem Cell Biomanufacturing Business (2021–2026)
Figure 53. Danaher Life Sciences Revenue Growth Rate in Stem Cell Biomanufacturing Business (2021–2026)
Figure 54. Iovance Biotherapeutics Revenue Growth Rate in Stem Cell Biomanufacturing Business (2021–2026)
Figure 55. Lisata Therapeutics Revenue Growth Rate in Stem Cell Biomanufacturing Business (2021–2026)
Figure 56. Lonza Revenue Growth Rate in Stem Cell Biomanufacturing Business (2021–2026)
Figure 57. Merck KGaA Revenue Growth Rate in Stem Cell Biomanufacturing Business (2021–2026)
Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Stem Cell Biomanufacturing Business (2021–2026)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies